Awakn Life Sciences Corp.
Awakn Life Sciences Corp. (AWKNF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
awknf · pe ratio · data through Jan 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Awakn Life Sciences Corp. (AWKNF) measures how much investors pay for each dollar of the company's trailing earnings. AWKNF's current PE ratio of N/A is calculated by dividing its stock price of $0.07 by its TTM earnings per share of -$0.36.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-01-31
PE Ratio History
2021 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Awakn Life Sciences Corp.You AWKNF | $3M | N/A | — | -$0.36 |
 ATI Physical Therapy, Inc. ATIP | $3M | N/A | — | -$13.49 |
 BerGenBio ASA BRRGF | $9.5B | N/A | — | -$125.06 |
 Pideka Group Inc. CIMVF | $3M | N/A | — | -$0.01 |
 Delta 9 Cannabis Inc. DLTNF | $3M | N/A | — | -$0.10 |
 Eve & Co Incorporated EEVVF | $3M | N/A | — | -$0.27 |
 Empower Clinics Inc. EPWCF | $3M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-01-31Latest FY2024 | — | $-0.18 | — | |
2023-01-31 FY2023 | — | $-0.36 | — | |
2022-01-31 FY2022 | — | $-0.73 | — | |
2021-01-31 FY2021 | — | $-0.10 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Awakn Life Sciences Corp. (AWKNF) measures how much investors pay for each dollar of the company's trailing earnings. AWKNF's current PE ratio of N/A is calculated by dividing its stock price of $0.07 by its TTM earnings per share of -$0.36.
Frequently asked questions
AWKNF pe ratio · 6 questionsAWKNF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.07 and TTM EPS of -$0.36. Data sourced from Financial Modeling Prep via AWKNF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Awakn Life Sciences Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09